0001209191-14-038324.txt : 20140623
0001209191-14-038324.hdr.sgml : 20140623
20140602161115
ACCESSION NUMBER: 0001209191-14-038324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140529
FILED AS OF DATE: 20140602
DATE AS OF CHANGE: 20140602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Endo International plc
CENTRAL INDEX KEY: 0001593034
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: 1
BUSINESS PHONE: 416-216-0000
MAIL ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: 1
FORMER COMPANY:
FORMER CONFORMED NAME: Endo International Ltd
DATE OF NAME CHANGE: 20131203
FORMER COMPANY:
FORMER CONFORMED NAME: Sportwell Ltd
DATE OF NAME CHANGE: 20131126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MANOGUE CAROLINE B
CENTRAL INDEX KEY: 0001179357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36326
FILM NUMBER: 14884220
MAIL ADDRESS:
STREET 1: 1400 ATWATER DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-05-29
0
0001593034
Endo International plc
ENDP
0001179357
MANOGUE CAROLINE B
C/O ENDO INTERNATIONAL PLC
33 FITZWILLIAM SQUARE
DUBLIN
L2
2
IRELAND
0
1
0
0
Exec. V.P., CLO & Secy
Ordinary Shares
2014-05-29
4
M
0
42279
30.55
A
76842
D
Ordinary Shares
2014-05-29
4
M
0
50000
24.87
A
126842
D
Ordinary Shares
2014-05-29
4
M
0
40722
25.19
A
167564
D
Ordinary Shares
2014-05-29
4
M
0
42032
19.93
A
209596
D
Ordinary Shares
2014-05-29
4
S
0
175033
72.02
D
34563
D
2004 Stock Incentive Plan Stock Options (NQ)
30.55
2014-05-29
4
M
0
42279
0.00
D
2017-02-21
Ordinary Shares
42279
0
D
2007 Stock Incentive Plan Stock Options (NQ)
24.87
2014-05-29
4
M
0
50000
0.00
D
2018-01-25
Ordinary Shares
50000
0
D
2007 Stock Incentive Plan Stock Options (NQ)
25.19
2014-05-29
4
M
0
40722
0.00
D
2018-02-21
Ordinary Shares
40722
0
D
2007 Stock Incentive Plan Stock Options (NQ)
19.93
2014-05-29
4
M
0
42032
0.00
D
2019-02-26
Ordinary Shares
42032
42033
D
On March 10, 2014, in connection with her personal financial planning, Ms. Manogue placed 175,033 of the shares underlying her stock options into a 10b5-1 pre-set selling program (as amended, the "Manogue Pre-Set Selling Program"). The options exercised and the shares sold above were sold pursuant to the Manogue Pre-Set Selling Program, which leaves no remaining shares (underlying options) in the current Manogue Pre-Set Selling Program.
This represents the average price at which Ms. Manogue's ordinary shares were sold on May 29, 2014.
Ms. Manogue's stock options that were granted under the 2004 Stock Incentive Plan on February 21, 2007 were generally exercisable 25% per year on each of February 21, 2008, February 21, 2009, February 21, 2010, and February 21, 2011.
These securities were granted to Ms. Manogue in consideration of her services as the Executive Vice President, Chief Legal Officer and Secretary of Endo Health Solutions Inc.
Ms. Manogue's stock options that were granted under the 2007 Stock Incentive Plan on January 25, 2008 were generally exercisable 50% per year on each of January 25, 2009 and January 25, 2010.
Ms. Manogue's stock options that were granted under the 2007 Stock Incentive Plan on February 21, 2008 were generally exercisable 25% per year on each of February 21, 2009, February 21, 2010, February 21, 2011, and February 21, 2012.
Ms. Manogue's stock options that were granted under the 2007 Stock Incentive Plan on February 26, 2009 were generally exercisable 25% per year on each of February 26, 2010, February 26, 2011, February 26, 2012, and February 26, 2013.
/s/ Caroline B. Manogue
2014-06-02
EX-24.4_525727
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these present that the undersigned hereby makes, constitutes and
appoints Caroline B. Manogue, Daniel A. Rudio, Richard Casten and Justin Dailey
as the undersigned's true and lawful attorneys-in-fact, with full power and
authority as hereinafter described on behalf of and in the name, place and stead
of each of the undersigned to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including
any amendments thereto) with respect to the securities of Endo International
plc, an Irish public limited company (the "Company"), with the United States
Securities and Exchange Commission, any national securities exchanges and the
Company, as considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the "Exchange Act");
(2) seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and
(3) perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.
The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.
This Power of Attorney shall remain in full force and effect with respect to
each undersigned until revoked by such undersigned in a signed writing delivered
to such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 23rd day of April 2014.
SIGNATURE TITLE
/s/ CAROLINE B. MANOGUE Executive Vice President, Chief Legal Officer
Caroline B. Manogue and Secretary
STATE OF PENNSYLVANIA:
COUNTY OF CHESTER:
On this 23rd day of April 2014, the above-named individual personally appeared
before me, and acknowledged that he executed the foregoing instrument for the
purposes therein contained.
IN WITNESS WHEREOF, I have hereunto set my hand and official seal.
/s/ SUSAN E. DEAR
Notary Public